相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Multilineage dysplasia has no impact on biologic, clinicopathologic, and prognostic features of AML with mutated nucleophosmin (NPM1)
Brunangelo Falini et al.
BLOOD (2010)
Transcription factor mutations in myelodysplastic/myeloproliferative neoplasms
Thomas Ernst et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Mutation analysis for RUNX1, MLL-PTD, FLT3-ITD, NPM1 and NRAS in 269 patients with MDS or secondary AML
F. Dicker et al.
LEUKEMIA (2010)
Minimal residual disease levels assessed by NPM1 mutation-specific RQ-PCR provide important prognostic information in AML
Susanne Schnittger et al.
BLOOD (2009)
Cuplike Nuclei (Prominent Nuclear Invaginations) in Acute Myeloid Leukemia Are Highly Associated With FLT3 Internal Tandem Duplication and NPM1 Mutation
Weina Chen et al.
CANCER (2009)
A dose-dependent tug of war involving the NPM1 leukaemic mutant, nucleophosmin, and ARF
N. Bolli et al.
LEUKEMIA (2009)
Altered nucleophosmin transport in acute myeloid leukaemia with mutated NPM1: molecular basis and clinical implications
B. Falini et al.
LEUKEMIA (2009)
FLT3 internal tandem duplication during myelodysplastic syndrome follow-up:: a marker of transformation to acute myeloid leukemia
Ronald Feitosa Pinheiro et al.
CANCER GENETICS AND CYTOGENETICS (2008)
Cup-like acute myeloid leukemia: new disease or artificial phenomenon?
Frank P. Kroschinsky et al.
HAEMATOLOGICA (2008)
A one-mutation mathematical model can explain the age incidence of acute myeloid leukemia with mutated nucleophosmin (NPM1)
Arcangelo Liso et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2008)
Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia
Richard F. Schlenk et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Prognostic relevance of FLT3-TKD mutations in AML:: the combination matters -: an analysis of 3082 patients
Ulrike Bacher et al.
BLOOD (2008)
The impact of FLT3 internal tandem duplication mutant level, number, size, and interaction with NPM1 mutations in a large cohort of young adult patients with acute myeloid leukemia
Rosemary E. Gale et al.
BLOOD (2008)
A comparative study of molecular mutations in 381 patients with myelodysplastic syndrome and in 4130 patients with acute myeloid leukemia
Ulrike Bacher et al.
HAEMATOLOGICA (2007)
Acute myeloid leukemia carrying cytoplasmic/mutated nucleophosmin (NPMc+ AML):: biologic and clinical features
Brunangelo Falini et al.
BLOOD (2007)
Lack of nucleophosmin mutation in patients with myelodysplastic syndrome and acute myeloid leukemia with chromosome 5 abnormalities
Masayuki Shiseki et al.
LEUKEMIA & LYMPHOMA (2007)
NPM1 mutations in myelodysplastic syndromes and acute myeloid leukemia with normal karyotype
Yue Zhang et al.
LEUKEMIA RESEARCH (2007)
Report on two novel nucleotide exchanges in the JAK2 pseudokinase domain:: D620E and E627E
S. Schnittger et al.
LEUKEMIA (2006)
Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML)
Christian Thiede et al.
BLOOD (2006)
Implications of NRAS mutations in AML:: a study of 2502 patients
Ulrike Bacher et al.
BLOOD (2006)
KIT-D816 mutations in AML1-ETO-positive AML are associated with impaired event-free and overall survival
S Schnittger et al.
BLOOD (2006)
Mutations in nucleophosmin (NPM1) in acute myeloid leukemia (AML):: association with other gene abnormalities and previously established gene expression signatures and their favorable prognostic significance
RGW Verhaak et al.
BLOOD (2005)
Nucleophosmin gene mutations are predictors of favorable prognosis in acute myelogenous leukemia with a normal karyotype
S Schnittger et al.
BLOOD (2005)
Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics:: interaction with other gene mutations
K Döhner et al.
BLOOD (2005)
Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype.
B Falini et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Determination of relapse risk based on assessment of minimal residual disease during complete remission by multiparameter flow cytometry in unselected patients with acute myeloid leukemia
W Kern et al.
BLOOD (2004)
Revised recommendations of the international working group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia
BD Cheson et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome
J Cools et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
The emergence of a C/EBPα mutation in the clonal evolution of MDS towards secondary AML
A Kaeferstein et al.
LEUKEMIA (2003)
Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia:: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease
S Schnittger et al.
BLOOD (2002)
Comparison of chromosome banding analysis, interphase- and hypermetaphase-FISH, qualitative and quantitative PCR for diagnosis and for follow-up in chronic myeloid leukemia: a study on 350 cases
C Schoch et al.
LEUKEMIA (2002)
Screening for MLL tandem duplication in 387 unselected patients with AML identify a prognostically unfavorable subset of AML
S Schnittger et al.
LEUKEMIA (2000)
分享论文
